$PCRX
Pacira Biosciences Inc

2024 Q3 Form 10-Q Financial Statement

#000139681424000098 Filed on July 30, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $168.6M $178.0M
YoY Change 2.83% 5.05%
Cost Of Revenue $38.86M $44.26M
YoY Change -2.23% -8.18%
Gross Profit $129.7M $133.8M
YoY Change 4.46% 10.31%
Gross Profit Margin 76.95% 75.14%
Selling, General & Admin $74.33M $68.13M
YoY Change 9.4% 5.05%
% of Gross Profit 57.31% 50.93%
Research & Development $19.10M $20.34M
YoY Change -8.29% 8.04%
% of Gross Profit 14.73% 15.2%
Depreciation & Amortization $6.000M $4.500M
YoY Change 46.34% -76.38%
% of Gross Profit 4.63% 3.36%
Operating Expenses $93.44M $88.46M
YoY Change 5.25% -9.73%
Operating Profit -$139.5M $28.24M
YoY Change -887.35% 21.39%
Interest Expense $793.0K $865.0K
YoY Change -77.11% -149.32%
% of Operating Profit 3.06%
Other Income/Expense, Net $671.0K $8.344M
YoY Change -159.91% -3201.86%
Pretax Income -$138.9M $36.58M
YoY Change -936.43% -3.35%
Income Tax $4.610M $17.70M
% Of Pretax Income 48.38%
Net Earnings -$143.5M $18.89M
YoY Change -1421.29% -26.69%
Net Earnings / Revenue -85.11% 10.61%
Basic Earnings Per Share -$3.11 $0.41
Diluted Earnings Per Share -$3.11 $0.39
COMMON SHARES
Basic Shares Outstanding 46.13M shares 46.55M shares
Diluted Shares Outstanding 46.13M shares 50.54M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $453.8M $404.2M
YoY Change 92.95% 83.1%
Cash & Equivalents $246.0M $247.1M
Short-Term Investments $207.8M $157.2M
Other Short-Term Assets $23.64M $19.77M
YoY Change 27.1% 13.96%
Inventory $111.9M $103.4M
Prepaid Expenses
Receivables $100.7M $104.8M
Other Receivables $0.00 $0.00
Total Short-Term Assets $690.0M $632.2M
YoY Change 54.27% 47.26%
LONG-TERM ASSETS
Property, Plant & Equipment $166.9M $168.9M
YoY Change -5.08% -31.4%
Goodwill $0.00 $163.2M
YoY Change -100.0% 0.0%
Intangibles $440.3M $454.6M
YoY Change -11.51% -11.19%
Long-Term Investments $36.73M $36.50M
YoY Change 3.45% 2.45%
Other Assets $134.0M $135.1M
YoY Change -11.65% -13.45%
Total Long-Term Assets $831.7M $1.015B
YoY Change -23.5% -8.85%
TOTAL ASSETS
Total Short-Term Assets $690.0M $632.2M
Total Long-Term Assets $831.7M $1.015B
Total Assets $1.522B $1.647B
YoY Change -0.83% 6.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $19.37M $18.73M
YoY Change 17.3% -22.62%
Accrued Expenses $76.38M $64.81M
YoY Change 27.54% -0.6%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $201.5M $0.00
YoY Change 2242.63% -100.0%
Total Short-Term Liabilities $306.4M $92.69M
YoY Change 227.14% -14.89%
LONG-TERM LIABILITIES
Long-Term Debt $385.9M $589.3M
YoY Change -25.2% 10.73%
Other Long-Term Liabilities $12.78M $13.01M
YoY Change 7.02% -86.06%
Total Long-Term Liabilities $12.78M $13.01M
YoY Change 7.02% -97.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $306.4M $92.69M
Total Long-Term Liabilities $12.78M $13.01M
Total Liabilities $772.1M $767.5M
YoY Change 9.84% 4.51%
SHAREHOLDERS EQUITY
Retained Earnings -$222.4M -$78.93M
YoY Change 68.91% -44.62%
Common Stock $47.00K $47.00K
YoY Change 2.17% 2.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $749.6M $879.3M
YoY Change
Total Liabilities & Shareholders Equity $1.522B $1.647B
YoY Change -0.83% 6.77%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$143.5M $18.89M
YoY Change -1421.29% -26.69%
Depreciation, Depletion And Amortization $6.000M $4.500M
YoY Change 46.34% -76.38%
Cash From Operating Activities $53.92M $53.24M
YoY Change 21.17% 22.38%
INVESTING ACTIVITIES
Capital Expenditures $4.092M $1.590M
YoY Change 20.35% -53.29%
Acquisitions
YoY Change
Other Investing Activities -$48.07M -$13.62M
YoY Change 4707.1% -226.98%
Cash From Investing Activities -$52.16M -$15.22M
YoY Change 1113.09% -307.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.845M 24.98M
YoY Change -89.77% 5577.27%
NET CHANGE
Cash From Operating Activities 53.92M 53.24M
Cash From Investing Activities -52.16M -15.22M
Cash From Financing Activities -2.845M 24.98M
Net Change In Cash -1.088M 63.00M
YoY Change -108.77% 22.89%
FREE CASH FLOW
Cash From Operating Activities $53.92M $53.24M
Capital Expenditures $4.092M $1.590M
Free Cash Flow $49.83M $51.65M
YoY Change 21.24% 28.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46481174 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46481174 shares
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
129590000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
28240000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
39877000 usd
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
4749000 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
2111000 usd
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
7518000 usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-39000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-269000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8344000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2023000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
36584000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
37854000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17698000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12091000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
18886000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.41
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46174000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46088000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50539000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52054000 shares
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
18886000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
25763000 usd
CY2024Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-52000 usd
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-35000 usd
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
5000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-47000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-36000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18839000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
807975000 usd
CY2024Q2 pcrx Contingent Consideration Gain Loss Restructuring Charges And Other
ContingentConsiderationGainLossRestructuringChargesAndOther
-2735000 usd
CY2023Q2 pcrx Contingent Consideration Gain Loss Restructuring Charges And Other
ContingentConsiderationGainLossRestructuringChargesAndOther
16613000 usd
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
149783000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
50224000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11380000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22359000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5153000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
25763000 usd
us-gaap Net Income Loss
NetIncomeLoss
27865000 usd
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
93755000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-17329000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104139000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
247053000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86810000 usd
pcrx Contingent Consideration Gain Loss Restructuring Charges And Other
ContingentConsiderationGainLossRestructuringChargesAndOther
-4638000 usd
pcrx Contingent Consideration Gain Loss Restructuring Charges And Other
ContingentConsiderationGainLossRestructuringChargesAndOther
4506000 usd
us-gaap Costs And Expenses
CostsAndExpenses
303688000 usd
us-gaap Costs And Expenses
CostsAndExpenses
293022000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
41452000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
36786000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
8652000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
5253000 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
3884000 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
3865000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
7200000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
13454000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
7518000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-16926000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-198000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-279000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8772000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-25406000 usd
us-gaap Net Income Loss
NetIncomeLoss
6227000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.60
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46337000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46019000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51366000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46285000 shares
us-gaap Net Income Loss
NetIncomeLoss
27865000 usd
us-gaap Net Income Loss
NetIncomeLoss
6227000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-160000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
216000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
18000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-9000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-142000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
207000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
25727000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
27723000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6434000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
892162000 usd
CY2024Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
378000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1364000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12524000 usd
CY2024Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
25121000 usd
CY2024Q2 pcrx Adjustments To Additional Paid In Capital Purchase Of Capped Calls Net Of Tax
AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallsNetOfTax
20112000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-47000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
18886000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
879278000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
768041000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1580000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1672000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10955000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-36000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
25763000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
870130000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
382000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1364000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25675000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
25121000 usd
pcrx Adjustments To Additional Paid In Capital Purchase Of Capped Calls Net Of Tax
AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallsNetOfTax
20112000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-142000 usd
us-gaap Net Income Loss
NetIncomeLoss
27865000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
879278000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
775010000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1914000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1672000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22945000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
207000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
807975000 usd
us-gaap Net Income Loss
NetIncomeLoss
27865000 usd
us-gaap Net Income Loss
NetIncomeLoss
6227000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
15998000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4100000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
37289000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
38656000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1444000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1628000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
47000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
703000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
7518000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-16926000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
25675000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
22945000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-2297000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-6640000 usd
us-gaap Provision For Other Losses
ProvisionForOtherLosses
109000 usd
us-gaap Provision For Other Losses
ProvisionForOtherLosses
11000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-776000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
683000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-915000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3933000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1309000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4369000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2772000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9683000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1361000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-30771000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-790000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
278000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
102337000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
62627000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4426000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9969000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
105781000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
69509000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
79462000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
159745000 usd
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
0 usd
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
6758000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-30745000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
73509000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1913000 usd
pcrx Proceeds From Shares Issued Under Employee Stock Purchase Plans
ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans
1364000 usd
pcrx Proceeds From Shares Issued Under Employee Stock Purchase Plans
ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans
1673000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
382000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
25000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
287500000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
149550000 usd
us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
26709000 usd
us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
0 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
5750000 usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
9350000 usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
1163000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22163000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-153465000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
153298000 usd
us-gaap Interest Paid Net
InterestPaidNet
6988000 usd
us-gaap Interest Paid Net
InterestPaidNet
20802000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4667000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
795000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
604000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2388000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
52340000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
54099000 usd
CY2024Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
23649000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
31215000 usd
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
27449000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
19039000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
103438000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
104353000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
292645000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
309233000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
123795000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
135306000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
168850000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
173927000 usd
CY2024Q2 us-gaap Depreciation
Depreciation
4500000 usd
CY2024Q2 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
700000 usd
us-gaap Depreciation
Depreciation
8600000 usd
us-gaap Depreciation
Depreciation
10000000.0 usd
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
1400000 usd
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
2100000 usd
CY2024Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
4000000 usd
CY2023Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
4300000 usd
CY2024Q2 pcrx Number Of Leases
NumberOfLeases
2 lease
us-gaap Operating Lease Cost
OperatingLeaseCost
6957000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
7259000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
783000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
945000 usd
us-gaap Sublease Income
SubleaseIncome
192000 usd
us-gaap Sublease Income
SubleaseIncome
322000 usd
us-gaap Lease Cost
LeaseCost
7548000 usd
us-gaap Lease Cost
LeaseCost
7882000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
6429000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
7325000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y6M29D
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y4M20D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0700
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0703
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
6516000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
12788000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
12823000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12587000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
10924000 usd
CY2024Q2 pcrx Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
16426000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
72064000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
12769000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
59295000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
163200000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
163200000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
590090000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
170342000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
419748000 usd
CY2024Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
624956000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
170342000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
454614000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
590090000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
141698000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
448392000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
624956000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
141698000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
483258000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
28600000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
28600000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
57300000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
57300000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
57300000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
57300000 usd
CY2024Q2 pcrx Finite Lived Intangible Asset Expected Amortization Year Six
FiniteLivedIntangibleAssetExpectedAmortizationYearSix
57300000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
57300000 usd
CY2024Q2 pcrx Finite Lived Intangible Asset Expected Amortization Year Seven
FiniteLivedIntangibleAssetExpectedAmortizationYearSeven
37400000 usd
CY2024Q2 pcrx Finite Lived Intangible Asset Expected Amortization Year Eight
FiniteLivedIntangibleAssetExpectedAmortizationYearEight
7900000 usd
CY2024Q2 pcrx Finite Lived Intangible Asset Expected Amortization Year Nine
FiniteLivedIntangibleAssetExpectedAmortizationYearNine
2200000 usd
CY2024Q2 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
150000000 usd
CY2024Q2 us-gaap Share Price
SharePrice
29.86
CY2024Q2 us-gaap Share Price
SharePrice
29.86
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
7108000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
13199000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1444000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1628000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
47000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
703000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1399000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
2076000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
7200000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
13454000 usd
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0298
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0438
CY2024Q2 us-gaap Share Price
SharePrice
28.61
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
21192000 usd
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
6758000 usd
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
61000 usd
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
28011000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-139000 usd
CY2024Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
27872000 usd
CY2024Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
157323000 usd
CY2024Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
9000 usd
CY2024Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
159000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
127631000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
111000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
49000 usd
CY2024Q2 us-gaap Interest Receivable
InterestReceivable
200000 usd
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
400000 usd
pcrx Number Of Major Customers
NumberOfMajorCustomers
3 wholesaler
CY2023 pcrx Number Of Major Customers
NumberOfMajorCustomers
3 wholesaler
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-100000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
200000 usd
CY2024Q2 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
150000000 usd
CY2024Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
837240 shares
CY2024Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
25100000 usd
CY2024Q2 pcrx Accrued Excise Tax On Treasury Stock
AccruedExciseTaxOnTreasuryStock
100000 usd
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12524000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10955000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
25675000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
22945000 usd
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12524000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10955000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
25675000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
22945000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7079748 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
49.40
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1099223 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
31.46
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
539743 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
45.57
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
692325 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
61.76
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6946903 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.69
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.42
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.85
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
56077 shares
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
18886000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
25763000 usd
us-gaap Net Income Loss
NetIncomeLoss
27865000 usd
us-gaap Net Income Loss
NetIncomeLoss
6227000 usd
CY2024Q2 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
19648000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
26792000 usd
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
29655000 usd
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
6227000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46174000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46088000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46337000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46019000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50539000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52054000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51366000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46285000 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.41
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.60
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8615000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6105000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8779000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11769000 shares
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
36996000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
40189000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
50653000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
12416000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-412000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-2335000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-429000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-1036000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
36584000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
37854000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
50224000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11380000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17698000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12091000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22359000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5153000 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.48
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.32
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.45
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.45
CY2024Q2 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
1000000 usd
CY2023Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
1000000 usd
CY2024Q2 us-gaap Restructuring Charges
RestructuringCharges
996000 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
936000 usd
us-gaap Restructuring Charges
RestructuringCharges
6531000 usd
us-gaap Restructuring Charges
RestructuringCharges
936000 usd
CY2024Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
230000 usd
CY2023Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
709000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
404000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1198000 usd
CY2024Q2 pcrx Contingent Consideration Gain Loss Restructuring Charges And Other
ContingentConsiderationGainLossRestructuringChargesAndOther
-2735000 usd
CY2023Q2 pcrx Contingent Consideration Gain Loss Restructuring Charges And Other
ContingentConsiderationGainLossRestructuringChargesAndOther
16613000 usd
pcrx Contingent Consideration Gain Loss Restructuring Charges And Other
ContingentConsiderationGainLossRestructuringChargesAndOther
-4638000 usd
pcrx Contingent Consideration Gain Loss Restructuring Charges And Other
ContingentConsiderationGainLossRestructuringChargesAndOther
4506000 usd
CY2024Q2 us-gaap Restructuring Charges
RestructuringCharges
1000000 usd
us-gaap Restructuring Charges
RestructuringCharges
6500000 usd
us-gaap Restructuring Charges
RestructuringCharges
900000 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
900000 usd
CY2023Q3 pcrx Litigation Settlement Amount Expected To Be Awarded From Other Party
LitigationSettlementAmountExpectedToBeAwardedFromOtherParty
14500000 usd
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001396814-24-000098-index-headers.html Edgar Link pending
0001396814-24-000098-index.html Edgar Link pending
0001396814-24-000098.txt Edgar Link pending
0001396814-24-000098-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pcrx-20240630.htm Edgar Link pending
pcrx-20240630.xsd Edgar Link pending
pcrx-20240630_g1.jpg Edgar Link pending
pcrx-20240630_g2.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pcrx-20240630_cal.xml Edgar Link unprocessable
pcrx-20240630_def.xml Edgar Link unprocessable
pcrx-20240630_lab.xml Edgar Link unprocessable
pcrx-20240630_htm.xml Edgar Link completed
pcrx-6302024xex311.htm Edgar Link pending
pcrx-6302024xex312.htm Edgar Link pending
pcrx-6302024xex321.htm Edgar Link pending
pcrx-exhibit103x6x30x2024.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pcrx-20240630_pre.xml Edgar Link unprocessable